#Chromium picolinate weight loss reviews trial

The clinical relevance of the effect is debatable and the lack of robustness means that the result has to be interpreted with caution. In conclusion, our meta-analysis suggests a relatively small effect of chromium picolinate compared with placebo for reducing body weight. Three of the reviewed trials reported on adverse events, indicating their absence in the treatment groups.

#Chromium picolinate weight loss reviews trial

Sensitivity analysis suggests that this effect is largely dependent on the results of a single trial (weighted mean difference: -0.9 kg 95% CI: -2.0 to 0.2 kg, n=335). For body weight a significant differential effect was found in favour of chromium picolinate (weighted mean difference: -1.1 kg 95% confidence interval (CI): -1.8 to -0.4 kg, n=489). Ten trials met all inclusion criteria and provided data, which were suitable for statistical pooling. To be included, studies were required to state that they were randomized, double-blind and placebo-controlled, and report on body weight. The screening of studies, selection, data extraction, validation and the assessment of methodological quality were performed independently by two reviewers. There were no restrictions regarding the language of publication. For Weight Loss (Obesity/Overweight) 'This is an early review as I just started it on 10/16/16 but the food cravings are gone, it takes less food to satisfy me, soda tastes terrible, cigarettes taste different and bad (which is a surprising good side effect.

Nine experts and four manufacturers of commercial preparations containing chromium picolinate were asked to contribute published and unpublished studies. 437 reviews submitted with a 5.9 average score. Literature searches were conducted on Medline, Embase, The Cochrane Library, Amed and Ciscom. The aim of this meta-analysis was to assess the evidence of chromium picolinate for reducing body weight.